Type 2 diabetes Trials in Meridian, United States
Conditions / Type 2 diabetes / Meridian, United States
Type 2 diabetes is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06993792 | A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes | ACTIVE_NOT_RECRUITING | — |
| NCT05872620 | A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT06972472 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes | RECRUITING | PHASE3 |
| NCT02973100 | A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy | COMPLETED | PHASE2 |
| NCT02739984 | Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia | COMPLETED | PHASE3 |
| NCT06221969 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor | COMPLETED | — |
| NCT01455857 | A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT06323161 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin | COMPLETED | PHASE3 |
| NCT01785771 | A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c | TERMINATED | PHASE3 |
| NCT01621178 | A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) | COMPLETED | PHASE3 |